Earnest Partners LLC Novartis Ag Transaction History
Earnest Partners LLC
- $21.8 Billion
- Q3 2025
A detailed history of Earnest Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Earnest Partners LLC holds 840,026 shares of NVS stock, worth $111 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
840,026
Previous 850,207
1.2%
Holding current value
$111 Million
Previous $103 Million
4.71%
% of portfolio
0.49%
Previous 0.49%
Shares
34 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...